Spinraza 12mg/5ml, Lösung zur intrathekalen Injektion
7680664950014
CH-66495
Lösung
Associated product:
SPINRAZA sol inj 12 mg/5ml flac
1 / 3
google
Article details
- Package size
- 5 ml
- Selling units
- 5
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
12.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
- | Substance | WIZUS |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 80736.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2020
Authorization holder
Biogen Switzerland AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66495
- Drug name
- Spinraza, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- M09AX
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 20/09/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SPINRAZA sol inj 12 mg/5ml flac
- Description (DE)
- SPINRAZA Inj Lös 12 mg/5ml Durchstf
- Market launch
- 20/09/2017
- Narcotic (BTM)
- No
Application methods
ITHE